Profile picture

Professor Paul Hjemdahl

Karolinska University Hospital, Stockholm (Sweden)
Membership: FESC Member
Follow
Biography
Senior professor/consultant, Clinical Pharmacology, Karolinska University Hospital/Solna. Research interests: sympatho-adrenal function and stress mechanisms in humans, hypertension, platelet function and antiplatelet therapy, chronic ischemic heart disease (APSIS study), diabetes, atrial fibrillation and oral anticoagulants. More than 300 original articles and >150 other publications. Tutored 28 PhD thesises. Previously much involved in ethics in research (Ethics Prize of the Karolinska Institute 2009). FESC 1996, FAHA 2001.
Logo ESC

Contributor content

Concomitant oral anticoagulant and antidepressant therapy in patients with atrial fibrillation and risk of stroke and bleeding: a population based cohort study
Presentation
Concomitant oral anticoagulant and antidepressant therapy in patients with atrial fibrillation and risk of stroke and bleeding: a population based cohort study
High mortality in atrial fibrillation patients suffering ischemic stroke, intracranial hemorrhage or a gastrointestinal bleed and associations with the preceding antithrombotic treatment
Presentation
High mortality in atrial fibrillation patients suffering ischemic stroke, intracranial hemorrhage or a gastrointestinal bleed and associations with the preceding antithrombotic treatment

ESC 365 is supported by